nodes	percent_of_prediction	percent_of_DWPC	metapath
Aminolevulinic acid—Azelaic Acid—Vorinostat—hematologic cancer	0.673	1	CrCrCtD
Aminolevulinic acid—ALAD—hematopoietic system—hematologic cancer	0.00739	0.193	CbGeAlD
Aminolevulinic acid—ALAD—gonad—hematologic cancer	0.00562	0.146	CbGeAlD
Aminolevulinic acid—ALAD—blood—hematologic cancer	0.0049	0.128	CbGeAlD
Aminolevulinic acid—ALAD—bone marrow—hematologic cancer	0.00474	0.124	CbGeAlD
Aminolevulinic acid—ALAD—lung—hematologic cancer	0.00429	0.112	CbGeAlD
Aminolevulinic acid—ALAD—testis—hematologic cancer	0.00405	0.106	CbGeAlD
Aminolevulinic acid—ALAD—lymph node—hematologic cancer	0.00294	0.0765	CbGeAlD
Aminolevulinic acid—L-Glutamine—TGM6—hematologic cancer	0.00211	0.388	CrCbGaD
Aminolevulinic acid—L-Glutamine—GMPS—hematologic cancer	0.00211	0.388	CrCbGaD
Aminolevulinic acid—SLC15A2—blood—hematologic cancer	0.00134	0.035	CbGeAlD
Aminolevulinic acid—ALAD—Porphyrin metabolism—UGT1A1—hematologic cancer	0.00132	0.273	CbGpPWpGaD
Aminolevulinic acid—L-Glutamine—ASNS—hematologic cancer	0.00121	0.223	CrCbGaD
Aminolevulinic acid—SLC15A2—lung—hematologic cancer	0.00118	0.0307	CbGeAlD
Aminolevulinic acid—SLC15A2—testis—hematologic cancer	0.00111	0.029	CbGeAlD
Aminolevulinic acid—SLC15A2—lymph node—hematologic cancer	0.000806	0.021	CbGeAlD
Aminolevulinic acid—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC26A4—hematologic cancer	0.000104	0.0215	CbGpPWpGaD
Aminolevulinic acid—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC26A4—hematologic cancer	9.61e-05	0.0199	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—GMPS—hematologic cancer	9.08e-05	0.0188	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—FTCD—hematologic cancer	9.08e-05	0.0188	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—PHYH—hematologic cancer	9.08e-05	0.0188	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—SMPD3—hematologic cancer	8.3e-05	0.0172	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—B3GAT1—hematologic cancer	7.26e-05	0.015	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—DCK—hematologic cancer	7.26e-05	0.015	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—ASNS—hematologic cancer	7.26e-05	0.015	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—HDC—hematologic cancer	6.88e-05	0.0143	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—CDA—hematologic cancer	6.29e-05	0.013	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—PC—hematologic cancer	6.06e-05	0.0126	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—SLC35B2—hematologic cancer	5.85e-05	0.0121	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—GBA—hematologic cancer	5.85e-05	0.0121	CbGpPWpGaD
Aminolevulinic acid—Hepatobiliary disease—Methotrexate—hematologic cancer	5.52e-05	0.000198	CcSEcCtD
Aminolevulinic acid—Nausea—Bortezomib—hematologic cancer	5.51e-05	0.000198	CcSEcCtD
Aminolevulinic acid—Paraesthesia—Prednisolone—hematologic cancer	5.5e-05	0.000197	CcSEcCtD
Aminolevulinic acid—Vomiting—Thiotepa—hematologic cancer	5.5e-05	0.000197	CcSEcCtD
Aminolevulinic acid—Diarrhoea—Carmustine—hematologic cancer	5.5e-05	0.000197	CcSEcCtD
Aminolevulinic acid—Mental disorder—Prednisone—hematologic cancer	5.49e-05	0.000197	CcSEcCtD
Aminolevulinic acid—Nausea—Bleomycin—hematologic cancer	5.47e-05	0.000196	CcSEcCtD
Aminolevulinic acid—Infestation NOS—Epirubicin—hematologic cancer	5.46e-05	0.000196	CcSEcCtD
Aminolevulinic acid—Infestation—Epirubicin—hematologic cancer	5.46e-05	0.000196	CcSEcCtD
Aminolevulinic acid—Erythema—Prednisone—hematologic cancer	5.46e-05	0.000196	CcSEcCtD
Aminolevulinic acid—Rash—Thiotepa—hematologic cancer	5.45e-05	0.000196	CcSEcCtD
Aminolevulinic acid—Dermatitis—Thiotepa—hematologic cancer	5.45e-05	0.000195	CcSEcCtD
Aminolevulinic acid—Diarrhoea—Alitretinoin—hematologic cancer	5.45e-05	0.000195	CcSEcCtD
Aminolevulinic acid—Convulsion—Betamethasone—hematologic cancer	5.43e-05	0.000195	CcSEcCtD
Aminolevulinic acid—Convulsion—Dexamethasone—hematologic cancer	5.43e-05	0.000195	CcSEcCtD
Aminolevulinic acid—Headache—Thiotepa—hematologic cancer	5.42e-05	0.000194	CcSEcCtD
Aminolevulinic acid—Diarrhoea—Ifosfamide—hematologic cancer	5.38e-05	0.000193	CcSEcCtD
Aminolevulinic acid—Nausea—Vinorelbine—hematologic cancer	5.38e-05	0.000193	CcSEcCtD
Aminolevulinic acid—Gastrointestinal disorder—Etoposide—hematologic cancer	5.36e-05	0.000192	CcSEcCtD
Aminolevulinic acid—Body temperature increased—Cisplatin—hematologic cancer	5.36e-05	0.000192	CcSEcCtD
Aminolevulinic acid—ALAD—Metabolism—MTAP—hematologic cancer	5.35e-05	0.0111	CbGpPWpGaD
Aminolevulinic acid—Vomiting—Thalidomide—hematologic cancer	5.32e-05	0.000191	CcSEcCtD
Aminolevulinic acid—Pain—Etoposide—hematologic cancer	5.31e-05	0.000191	CcSEcCtD
Aminolevulinic acid—Rash—Thalidomide—hematologic cancer	5.27e-05	0.000189	CcSEcCtD
Aminolevulinic acid—Discomfort—Dexamethasone—hematologic cancer	5.27e-05	0.000189	CcSEcCtD
Aminolevulinic acid—Discomfort—Betamethasone—hematologic cancer	5.27e-05	0.000189	CcSEcCtD
Aminolevulinic acid—Dermatitis—Thalidomide—hematologic cancer	5.27e-05	0.000189	CcSEcCtD
Aminolevulinic acid—Haemoglobin—Methotrexate—hematologic cancer	5.26e-05	0.000189	CcSEcCtD
Aminolevulinic acid—Diarrhoea—Vincristine—hematologic cancer	5.25e-05	0.000188	CcSEcCtD
Aminolevulinic acid—Headache—Thalidomide—hematologic cancer	5.24e-05	0.000188	CcSEcCtD
Aminolevulinic acid—Pain—Prednisolone—hematologic cancer	5.24e-05	0.000188	CcSEcCtD
Aminolevulinic acid—Haemorrhage—Methotrexate—hematologic cancer	5.24e-05	0.000188	CcSEcCtD
Aminolevulinic acid—SLC15A2—SLC-mediated transmembrane transport—SLC35B2—hematologic cancer	5.19e-05	0.0108	CbGpPWpGaD
Aminolevulinic acid—Photosensitivity reaction—Doxorubicin—hematologic cancer	5.17e-05	0.000185	CcSEcCtD
Aminolevulinic acid—Hepatobiliary disease—Epirubicin—hematologic cancer	5.16e-05	0.000185	CcSEcCtD
Aminolevulinic acid—Pruritus—Gemcitabine—hematologic cancer	5.15e-05	0.000185	CcSEcCtD
Aminolevulinic acid—Nausea—Thiotepa—hematologic cancer	5.14e-05	0.000184	CcSEcCtD
Aminolevulinic acid—Oedema—Betamethasone—hematologic cancer	5.11e-05	0.000183	CcSEcCtD
Aminolevulinic acid—Oedema—Dexamethasone—hematologic cancer	5.11e-05	0.000183	CcSEcCtD
Aminolevulinic acid—Diarrhoea—Mitoxantrone—hematologic cancer	5.11e-05	0.000183	CcSEcCtD
Aminolevulinic acid—Diarrhoea—Irinotecan—hematologic cancer	5.11e-05	0.000183	CcSEcCtD
Aminolevulinic acid—Vomiting—Carmustine—hematologic cancer	5.11e-05	0.000183	CcSEcCtD
Aminolevulinic acid—Infection—Betamethasone—hematologic cancer	5.08e-05	0.000182	CcSEcCtD
Aminolevulinic acid—Infection—Dexamethasone—hematologic cancer	5.08e-05	0.000182	CcSEcCtD
Aminolevulinic acid—Rash—Carmustine—hematologic cancer	5.07e-05	0.000182	CcSEcCtD
Aminolevulinic acid—Dermatitis—Carmustine—hematologic cancer	5.06e-05	0.000182	CcSEcCtD
Aminolevulinic acid—Vomiting—Alitretinoin—hematologic cancer	5.06e-05	0.000181	CcSEcCtD
Aminolevulinic acid—Paraesthesia—Triamcinolone—hematologic cancer	5.06e-05	0.000181	CcSEcCtD
Aminolevulinic acid—Infestation NOS—Doxorubicin—hematologic cancer	5.05e-05	0.000181	CcSEcCtD
Aminolevulinic acid—Infestation—Doxorubicin—hematologic cancer	5.05e-05	0.000181	CcSEcCtD
Aminolevulinic acid—Anaemia—Prednisone—hematologic cancer	5.04e-05	0.000181	CcSEcCtD
Aminolevulinic acid—Headache—Carmustine—hematologic cancer	5.03e-05	0.000181	CcSEcCtD
Aminolevulinic acid—Rash—Alitretinoin—hematologic cancer	5.02e-05	0.00018	CcSEcCtD
Aminolevulinic acid—Nervous system disorder—Dexamethasone—hematologic cancer	5.01e-05	0.00018	CcSEcCtD
Aminolevulinic acid—Nervous system disorder—Betamethasone—hematologic cancer	5.01e-05	0.00018	CcSEcCtD
Aminolevulinic acid—Dermatitis—Alitretinoin—hematologic cancer	5.01e-05	0.00018	CcSEcCtD
Aminolevulinic acid—Thrombocytopenia—Dexamethasone—hematologic cancer	5.01e-05	0.00018	CcSEcCtD
Aminolevulinic acid—Thrombocytopenia—Betamethasone—hematologic cancer	5.01e-05	0.00018	CcSEcCtD
Aminolevulinic acid—Vomiting—Ifosfamide—hematologic cancer	5e-05	0.000179	CcSEcCtD
Aminolevulinic acid—Headache—Alitretinoin—hematologic cancer	4.99e-05	0.000179	CcSEcCtD
Aminolevulinic acid—Diarrhoea—Gemcitabine—hematologic cancer	4.98e-05	0.000179	CcSEcCtD
Aminolevulinic acid—Nausea—Thalidomide—hematologic cancer	4.97e-05	0.000178	CcSEcCtD
Aminolevulinic acid—Rash—Ifosfamide—hematologic cancer	4.96e-05	0.000178	CcSEcCtD
Aminolevulinic acid—Dermatitis—Ifosfamide—hematologic cancer	4.96e-05	0.000178	CcSEcCtD
Aminolevulinic acid—Urticaria—Etoposide—hematologic cancer	4.94e-05	0.000177	CcSEcCtD
Aminolevulinic acid—Haemoglobin—Epirubicin—hematologic cancer	4.93e-05	0.000177	CcSEcCtD
Aminolevulinic acid—Body temperature increased—Etoposide—hematologic cancer	4.91e-05	0.000176	CcSEcCtD
Aminolevulinic acid—Haemorrhage—Epirubicin—hematologic cancer	4.9e-05	0.000176	CcSEcCtD
Aminolevulinic acid—Eye disorder—Methotrexate—hematologic cancer	4.9e-05	0.000176	CcSEcCtD
Aminolevulinic acid—Hypoaesthesia—Epirubicin—hematologic cancer	4.88e-05	0.000175	CcSEcCtD
Aminolevulinic acid—Vomiting—Vincristine—hematologic cancer	4.88e-05	0.000175	CcSEcCtD
Aminolevulinic acid—Urticaria—Prednisolone—hematologic cancer	4.87e-05	0.000175	CcSEcCtD
Aminolevulinic acid—Cardiac disorder—Methotrexate—hematologic cancer	4.86e-05	0.000174	CcSEcCtD
Aminolevulinic acid—Rash—Vincristine—hematologic cancer	4.84e-05	0.000173	CcSEcCtD
Aminolevulinic acid—Dermatitis—Vincristine—hematologic cancer	4.83e-05	0.000173	CcSEcCtD
Aminolevulinic acid—Pain—Triamcinolone—hematologic cancer	4.82e-05	0.000173	CcSEcCtD
Aminolevulinic acid—SLC15A1—SLC-mediated transmembrane transport—SLC35B2—hematologic cancer	4.82e-05	0.00999	CbGpPWpGaD
Aminolevulinic acid—Headache—Vincristine—hematologic cancer	4.81e-05	0.000172	CcSEcCtD
Aminolevulinic acid—Hepatobiliary disease—Doxorubicin—hematologic cancer	4.78e-05	0.000171	CcSEcCtD
Aminolevulinic acid—Hypotension—Betamethasone—hematologic cancer	4.78e-05	0.000171	CcSEcCtD
Aminolevulinic acid—Hypotension—Dexamethasone—hematologic cancer	4.78e-05	0.000171	CcSEcCtD
Aminolevulinic acid—Nausea—Carmustine—hematologic cancer	4.77e-05	0.000171	CcSEcCtD
Aminolevulinic acid—ALAD—Metabolism—FHL2—hematologic cancer	4.77e-05	0.00988	CbGpPWpGaD
Aminolevulinic acid—Angiopathy—Methotrexate—hematologic cancer	4.75e-05	0.00017	CcSEcCtD
Aminolevulinic acid—Vomiting—Irinotecan—hematologic cancer	4.75e-05	0.00017	CcSEcCtD
Aminolevulinic acid—Vomiting—Mitoxantrone—hematologic cancer	4.75e-05	0.00017	CcSEcCtD
Aminolevulinic acid—Nausea—Alitretinoin—hematologic cancer	4.73e-05	0.00017	CcSEcCtD
Aminolevulinic acid—Convulsion—Prednisone—hematologic cancer	4.73e-05	0.00017	CcSEcCtD
Aminolevulinic acid—Rash—Mitoxantrone—hematologic cancer	4.71e-05	0.000169	CcSEcCtD
Aminolevulinic acid—Rash—Irinotecan—hematologic cancer	4.71e-05	0.000169	CcSEcCtD
Aminolevulinic acid—Dermatitis—Irinotecan—hematologic cancer	4.71e-05	0.000169	CcSEcCtD
Aminolevulinic acid—Dermatitis—Mitoxantrone—hematologic cancer	4.71e-05	0.000169	CcSEcCtD
Aminolevulinic acid—Chills—Methotrexate—hematologic cancer	4.7e-05	0.000169	CcSEcCtD
Aminolevulinic acid—Headache—Irinotecan—hematologic cancer	4.68e-05	0.000168	CcSEcCtD
Aminolevulinic acid—Headache—Mitoxantrone—hematologic cancer	4.68e-05	0.000168	CcSEcCtD
Aminolevulinic acid—ALAD—Metabolism—AGRN—hematologic cancer	4.68e-05	0.00969	CbGpPWpGaD
Aminolevulinic acid—Nausea—Ifosfamide—hematologic cancer	4.67e-05	0.000168	CcSEcCtD
Aminolevulinic acid—Diarrhoea—Cisplatin—hematologic cancer	4.64e-05	0.000166	CcSEcCtD
Aminolevulinic acid—SLC15A2—SLC-mediated transmembrane transport—SLC26A4—hematologic cancer	4.63e-05	0.00959	CbGpPWpGaD
Aminolevulinic acid—Vomiting—Gemcitabine—hematologic cancer	4.63e-05	0.000166	CcSEcCtD
Aminolevulinic acid—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	4.61e-05	0.000165	CcSEcCtD
Aminolevulinic acid—Paraesthesia—Betamethasone—hematologic cancer	4.59e-05	0.000165	CcSEcCtD
Aminolevulinic acid—Paraesthesia—Dexamethasone—hematologic cancer	4.59e-05	0.000165	CcSEcCtD
Aminolevulinic acid—Discomfort—Prednisone—hematologic cancer	4.59e-05	0.000165	CcSEcCtD
Aminolevulinic acid—Mental disorder—Methotrexate—hematologic cancer	4.59e-05	0.000165	CcSEcCtD
Aminolevulinic acid—Rash—Gemcitabine—hematologic cancer	4.59e-05	0.000165	CcSEcCtD
Aminolevulinic acid—Dermatitis—Gemcitabine—hematologic cancer	4.58e-05	0.000164	CcSEcCtD
Aminolevulinic acid—Eye disorder—Epirubicin—hematologic cancer	4.58e-05	0.000164	CcSEcCtD
Aminolevulinic acid—Erythema—Methotrexate—hematologic cancer	4.56e-05	0.000164	CcSEcCtD
Aminolevulinic acid—Haemoglobin—Doxorubicin—hematologic cancer	4.56e-05	0.000163	CcSEcCtD
Aminolevulinic acid—Headache—Gemcitabine—hematologic cancer	4.56e-05	0.000163	CcSEcCtD
Aminolevulinic acid—Nausea—Vincristine—hematologic cancer	4.56e-05	0.000163	CcSEcCtD
Aminolevulinic acid—Cardiac disorder—Epirubicin—hematologic cancer	4.55e-05	0.000163	CcSEcCtD
Aminolevulinic acid—Haemorrhage—Doxorubicin—hematologic cancer	4.54e-05	0.000163	CcSEcCtD
Aminolevulinic acid—Hypoaesthesia—Doxorubicin—hematologic cancer	4.51e-05	0.000162	CcSEcCtD
Aminolevulinic acid—Urticaria—Triamcinolone—hematologic cancer	4.48e-05	0.000161	CcSEcCtD
Aminolevulinic acid—Body temperature increased—Triamcinolone—hematologic cancer	4.46e-05	0.00016	CcSEcCtD
Aminolevulinic acid—Oedema—Prednisone—hematologic cancer	4.45e-05	0.00016	CcSEcCtD
Aminolevulinic acid—Angiopathy—Epirubicin—hematologic cancer	4.45e-05	0.000159	CcSEcCtD
Aminolevulinic acid—Nausea—Mitoxantrone—hematologic cancer	4.44e-05	0.000159	CcSEcCtD
Aminolevulinic acid—Nausea—Irinotecan—hematologic cancer	4.44e-05	0.000159	CcSEcCtD
Aminolevulinic acid—ALAD—Metabolism—IDH2—hematologic cancer	4.43e-05	0.00919	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—HMMR—hematologic cancer	4.43e-05	0.00919	CbGpPWpGaD
Aminolevulinic acid—Infection—Prednisone—hematologic cancer	4.42e-05	0.000159	CcSEcCtD
Aminolevulinic acid—Gastrointestinal disorder—Dexamethasone—hematologic cancer	4.41e-05	0.000158	CcSEcCtD
Aminolevulinic acid—Gastrointestinal disorder—Betamethasone—hematologic cancer	4.41e-05	0.000158	CcSEcCtD
Aminolevulinic acid—Chills—Epirubicin—hematologic cancer	4.4e-05	0.000158	CcSEcCtD
Aminolevulinic acid—Pruritus—Etoposide—hematologic cancer	4.4e-05	0.000158	CcSEcCtD
Aminolevulinic acid—Pain—Dexamethasone—hematologic cancer	4.37e-05	0.000157	CcSEcCtD
Aminolevulinic acid—Pain—Betamethasone—hematologic cancer	4.37e-05	0.000157	CcSEcCtD
Aminolevulinic acid—Nervous system disorder—Prednisone—hematologic cancer	4.37e-05	0.000157	CcSEcCtD
Aminolevulinic acid—Skin disorder—Prednisone—hematologic cancer	4.33e-05	0.000155	CcSEcCtD
Aminolevulinic acid—Nausea—Gemcitabine—hematologic cancer	4.32e-05	0.000155	CcSEcCtD
Aminolevulinic acid—Vomiting—Cisplatin—hematologic cancer	4.31e-05	0.000155	CcSEcCtD
Aminolevulinic acid—SLC15A1—SLC-mediated transmembrane transport—SLC26A4—hematologic cancer	4.29e-05	0.0089	CbGpPWpGaD
Aminolevulinic acid—Mental disorder—Epirubicin—hematologic cancer	4.29e-05	0.000154	CcSEcCtD
Aminolevulinic acid—Rash—Cisplatin—hematologic cancer	4.28e-05	0.000153	CcSEcCtD
Aminolevulinic acid—Dermatitis—Cisplatin—hematologic cancer	4.27e-05	0.000153	CcSEcCtD
Aminolevulinic acid—Erythema—Epirubicin—hematologic cancer	4.27e-05	0.000153	CcSEcCtD
Aminolevulinic acid—Diarrhoea—Etoposide—hematologic cancer	4.25e-05	0.000152	CcSEcCtD
Aminolevulinic acid—Eye disorder—Doxorubicin—hematologic cancer	4.24e-05	0.000152	CcSEcCtD
Aminolevulinic acid—Anaemia—Methotrexate—hematologic cancer	4.21e-05	0.000151	CcSEcCtD
Aminolevulinic acid—Cardiac disorder—Doxorubicin—hematologic cancer	4.21e-05	0.000151	CcSEcCtD
Aminolevulinic acid—Tension—Epirubicin—hematologic cancer	4.19e-05	0.00015	CcSEcCtD
Aminolevulinic acid—ALAD—Metabolism—ARNTL—hematologic cancer	4.17e-05	0.00864	CbGpPWpGaD
Aminolevulinic acid—Nervousness—Epirubicin—hematologic cancer	4.14e-05	0.000149	CcSEcCtD
Aminolevulinic acid—Angiopathy—Doxorubicin—hematologic cancer	4.12e-05	0.000148	CcSEcCtD
Aminolevulinic acid—Chills—Doxorubicin—hematologic cancer	4.07e-05	0.000146	CcSEcCtD
Aminolevulinic acid—Urticaria—Betamethasone—hematologic cancer	4.06e-05	0.000146	CcSEcCtD
Aminolevulinic acid—Urticaria—Dexamethasone—hematologic cancer	4.06e-05	0.000146	CcSEcCtD
Aminolevulinic acid—ALAD—Metabolism—ACP5—hematologic cancer	4.05e-05	0.0084	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—CA9—hematologic cancer	4.05e-05	0.0084	CbGpPWpGaD
Aminolevulinic acid—Body temperature increased—Betamethasone—hematologic cancer	4.04e-05	0.000145	CcSEcCtD
Aminolevulinic acid—Body temperature increased—Dexamethasone—hematologic cancer	4.04e-05	0.000145	CcSEcCtD
Aminolevulinic acid—Nausea—Cisplatin—hematologic cancer	4.03e-05	0.000144	CcSEcCtD
Aminolevulinic acid—ALAD—Metabolism—NCOR2—hematologic cancer	4e-05	0.00829	CbGpPWpGaD
Aminolevulinic acid—Paraesthesia—Prednisone—hematologic cancer	4e-05	0.000143	CcSEcCtD
Aminolevulinic acid—Pruritus—Triamcinolone—hematologic cancer	3.99e-05	0.000143	CcSEcCtD
Aminolevulinic acid—Mental disorder—Doxorubicin—hematologic cancer	3.97e-05	0.000143	CcSEcCtD
Aminolevulinic acid—Convulsion—Methotrexate—hematologic cancer	3.95e-05	0.000142	CcSEcCtD
Aminolevulinic acid—Vomiting—Etoposide—hematologic cancer	3.95e-05	0.000142	CcSEcCtD
Aminolevulinic acid—Erythema—Doxorubicin—hematologic cancer	3.95e-05	0.000142	CcSEcCtD
Aminolevulinic acid—Anaemia—Epirubicin—hematologic cancer	3.94e-05	0.000141	CcSEcCtD
Aminolevulinic acid—Rash—Etoposide—hematologic cancer	3.92e-05	0.00014	CcSEcCtD
Aminolevulinic acid—Dermatitis—Etoposide—hematologic cancer	3.91e-05	0.00014	CcSEcCtD
Aminolevulinic acid—Headache—Etoposide—hematologic cancer	3.89e-05	0.00014	CcSEcCtD
Aminolevulinic acid—Tension—Doxorubicin—hematologic cancer	3.87e-05	0.000139	CcSEcCtD
Aminolevulinic acid—Rash—Prednisolone—hematologic cancer	3.86e-05	0.000139	CcSEcCtD
Aminolevulinic acid—Dermatitis—Prednisolone—hematologic cancer	3.86e-05	0.000138	CcSEcCtD
Aminolevulinic acid—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	3.86e-05	0.000138	CcSEcCtD
Aminolevulinic acid—Headache—Prednisolone—hematologic cancer	3.84e-05	0.000138	CcSEcCtD
Aminolevulinic acid—Discomfort—Methotrexate—hematologic cancer	3.84e-05	0.000138	CcSEcCtD
Aminolevulinic acid—Nervousness—Doxorubicin—hematologic cancer	3.84e-05	0.000138	CcSEcCtD
Aminolevulinic acid—ALAD—Metabolism—IDH1—hematologic cancer	3.81e-05	0.0079	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—GSTO1—hematologic cancer	3.77e-05	0.00781	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—ABCC3—hematologic cancer	3.77e-05	0.00781	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—TXN—hematologic cancer	3.77e-05	0.00781	CbGpPWpGaD
Aminolevulinic acid—SLC15A2—Transmembrane transport of small molecules—AQP9—hematologic cancer	3.74e-05	0.00776	CbGpPWpGaD
Aminolevulinic acid—Convulsion—Epirubicin—hematologic cancer	3.7e-05	0.000133	CcSEcCtD
Aminolevulinic acid—Infection—Methotrexate—hematologic cancer	3.7e-05	0.000133	CcSEcCtD
Aminolevulinic acid—Nausea—Etoposide—hematologic cancer	3.69e-05	0.000132	CcSEcCtD
Aminolevulinic acid—ALAD—Metabolism—SPHK1—hematologic cancer	3.69e-05	0.00764	CbGpPWpGaD
Aminolevulinic acid—Nervous system disorder—Methotrexate—hematologic cancer	3.65e-05	0.000131	CcSEcCtD
Aminolevulinic acid—Anaemia—Doxorubicin—hematologic cancer	3.65e-05	0.000131	CcSEcCtD
Aminolevulinic acid—Thrombocytopenia—Methotrexate—hematologic cancer	3.64e-05	0.000131	CcSEcCtD
Aminolevulinic acid—Nausea—Prednisolone—hematologic cancer	3.64e-05	0.000131	CcSEcCtD
Aminolevulinic acid—Pruritus—Dexamethasone—hematologic cancer	3.62e-05	0.00013	CcSEcCtD
Aminolevulinic acid—Pruritus—Betamethasone—hematologic cancer	3.62e-05	0.00013	CcSEcCtD
Aminolevulinic acid—Skin disorder—Methotrexate—hematologic cancer	3.61e-05	0.00013	CcSEcCtD
Aminolevulinic acid—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	3.61e-05	0.000129	CcSEcCtD
Aminolevulinic acid—Discomfort—Epirubicin—hematologic cancer	3.59e-05	0.000129	CcSEcCtD
Aminolevulinic acid—Vomiting—Triamcinolone—hematologic cancer	3.58e-05	0.000128	CcSEcCtD
Aminolevulinic acid—Rash—Triamcinolone—hematologic cancer	3.55e-05	0.000127	CcSEcCtD
Aminolevulinic acid—Dermatitis—Triamcinolone—hematologic cancer	3.55e-05	0.000127	CcSEcCtD
Aminolevulinic acid—ALAD—Metabolism—UGT1A1—hematologic cancer	3.54e-05	0.00734	CbGpPWpGaD
Aminolevulinic acid—Urticaria—Prednisone—hematologic cancer	3.54e-05	0.000127	CcSEcCtD
Aminolevulinic acid—Headache—Triamcinolone—hematologic cancer	3.53e-05	0.000127	CcSEcCtD
Aminolevulinic acid—Body temperature increased—Prednisone—hematologic cancer	3.52e-05	0.000126	CcSEcCtD
Aminolevulinic acid—Diarrhoea—Betamethasone—hematologic cancer	3.5e-05	0.000125	CcSEcCtD
Aminolevulinic acid—Diarrhoea—Dexamethasone—hematologic cancer	3.5e-05	0.000125	CcSEcCtD
Aminolevulinic acid—Oedema—Epirubicin—hematologic cancer	3.48e-05	0.000125	CcSEcCtD
Aminolevulinic acid—SLC15A2—Transmembrane transport of small molecules—FXYD6—hematologic cancer	3.48e-05	0.00721	CbGpPWpGaD
Aminolevulinic acid—Hypotension—Methotrexate—hematologic cancer	3.48e-05	0.000125	CcSEcCtD
Aminolevulinic acid—SLC15A1—Transmembrane transport of small molecules—AQP9—hematologic cancer	3.48e-05	0.0072	CbGpPWpGaD
Aminolevulinic acid—Infection—Epirubicin—hematologic cancer	3.46e-05	0.000124	CcSEcCtD
Aminolevulinic acid—ALAD—Metabolism—SLC22A1—hematologic cancer	3.45e-05	0.00714	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—CRABP1—hematologic cancer	3.45e-05	0.00714	CbGpPWpGaD
Aminolevulinic acid—Convulsion—Doxorubicin—hematologic cancer	3.42e-05	0.000123	CcSEcCtD
Aminolevulinic acid—Nervous system disorder—Epirubicin—hematologic cancer	3.42e-05	0.000122	CcSEcCtD
Aminolevulinic acid—Thrombocytopenia—Epirubicin—hematologic cancer	3.41e-05	0.000122	CcSEcCtD
Aminolevulinic acid—Skin disorder—Epirubicin—hematologic cancer	3.38e-05	0.000121	CcSEcCtD
Aminolevulinic acid—ALAD—Metabolism—ALOX5—hematologic cancer	3.36e-05	0.00696	CbGpPWpGaD
Aminolevulinic acid—Nausea—Triamcinolone—hematologic cancer	3.35e-05	0.00012	CcSEcCtD
Aminolevulinic acid—Paraesthesia—Methotrexate—hematologic cancer	3.34e-05	0.00012	CcSEcCtD
Aminolevulinic acid—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	3.34e-05	0.00012	CcSEcCtD
Aminolevulinic acid—Discomfort—Doxorubicin—hematologic cancer	3.32e-05	0.000119	CcSEcCtD
Aminolevulinic acid—Hypotension—Epirubicin—hematologic cancer	3.25e-05	0.000117	CcSEcCtD
Aminolevulinic acid—ALAD—Metabolism—NUP98—hematologic cancer	3.25e-05	0.00674	CbGpPWpGaD
Aminolevulinic acid—Vomiting—Dexamethasone—hematologic cancer	3.25e-05	0.000117	CcSEcCtD
Aminolevulinic acid—Vomiting—Betamethasone—hematologic cancer	3.25e-05	0.000117	CcSEcCtD
Aminolevulinic acid—SLC15A1—Transmembrane transport of small molecules—FXYD6—hematologic cancer	3.23e-05	0.0067	CbGpPWpGaD
Aminolevulinic acid—Rash—Dexamethasone—hematologic cancer	3.22e-05	0.000116	CcSEcCtD
Aminolevulinic acid—Rash—Betamethasone—hematologic cancer	3.22e-05	0.000116	CcSEcCtD
Aminolevulinic acid—Oedema—Doxorubicin—hematologic cancer	3.22e-05	0.000116	CcSEcCtD
Aminolevulinic acid—Dermatitis—Betamethasone—hematologic cancer	3.22e-05	0.000116	CcSEcCtD
Aminolevulinic acid—Dermatitis—Dexamethasone—hematologic cancer	3.22e-05	0.000116	CcSEcCtD
Aminolevulinic acid—Gastrointestinal disorder—Methotrexate—hematologic cancer	3.21e-05	0.000115	CcSEcCtD
Aminolevulinic acid—Headache—Betamethasone—hematologic cancer	3.2e-05	0.000115	CcSEcCtD
Aminolevulinic acid—Headache—Dexamethasone—hematologic cancer	3.2e-05	0.000115	CcSEcCtD
Aminolevulinic acid—Infection—Doxorubicin—hematologic cancer	3.2e-05	0.000115	CcSEcCtD
Aminolevulinic acid—Pain—Methotrexate—hematologic cancer	3.18e-05	0.000114	CcSEcCtD
Aminolevulinic acid—Nervous system disorder—Doxorubicin—hematologic cancer	3.16e-05	0.000113	CcSEcCtD
Aminolevulinic acid—ALAD—Metabolism—ADCY7—hematologic cancer	3.16e-05	0.00655	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—NCOA3—hematologic cancer	3.16e-05	0.00655	CbGpPWpGaD
Aminolevulinic acid—Thrombocytopenia—Doxorubicin—hematologic cancer	3.16e-05	0.000113	CcSEcCtD
Aminolevulinic acid—Pruritus—Prednisone—hematologic cancer	3.15e-05	0.000113	CcSEcCtD
Aminolevulinic acid—ALAD—Metabolism—NUP214—hematologic cancer	3.14e-05	0.0065	CbGpPWpGaD
Aminolevulinic acid—Skin disorder—Doxorubicin—hematologic cancer	3.13e-05	0.000112	CcSEcCtD
Aminolevulinic acid—Paraesthesia—Epirubicin—hematologic cancer	3.13e-05	0.000112	CcSEcCtD
Aminolevulinic acid—ALAD—Metabolism—MTR—hematologic cancer	3.07e-05	0.00637	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—ABCG2—hematologic cancer	3.07e-05	0.00637	CbGpPWpGaD
Aminolevulinic acid—SLC15A2—SLC-mediated transmembrane transport—SLC22A1—hematologic cancer	3.06e-05	0.00634	CbGpPWpGaD
Aminolevulinic acid—Diarrhoea—Prednisone—hematologic cancer	3.05e-05	0.000109	CcSEcCtD
Aminolevulinic acid—Nausea—Dexamethasone—hematologic cancer	3.04e-05	0.000109	CcSEcCtD
Aminolevulinic acid—Nausea—Betamethasone—hematologic cancer	3.04e-05	0.000109	CcSEcCtD
Aminolevulinic acid—ALAD—Metabolism—ENO2—hematologic cancer	3.01e-05	0.00624	CbGpPWpGaD
Aminolevulinic acid—Hypotension—Doxorubicin—hematologic cancer	3.01e-05	0.000108	CcSEcCtD
Aminolevulinic acid—Gastrointestinal disorder—Epirubicin—hematologic cancer	3.01e-05	0.000108	CcSEcCtD
Aminolevulinic acid—Pain—Epirubicin—hematologic cancer	2.98e-05	0.000107	CcSEcCtD
Aminolevulinic acid—Urticaria—Methotrexate—hematologic cancer	2.96e-05	0.000106	CcSEcCtD
Aminolevulinic acid—Body temperature increased—Methotrexate—hematologic cancer	2.94e-05	0.000106	CcSEcCtD
Aminolevulinic acid—ALAD—Metabolism—GSTT1—hematologic cancer	2.92e-05	0.00606	CbGpPWpGaD
Aminolevulinic acid—Paraesthesia—Doxorubicin—hematologic cancer	2.89e-05	0.000104	CcSEcCtD
Aminolevulinic acid—SLC15A2—SLC-mediated transmembrane transport—NUP98—hematologic cancer	2.89e-05	0.00598	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—SDC1—hematologic cancer	2.86e-05	0.00592	CbGpPWpGaD
Aminolevulinic acid—SLC15A1—SLC-mediated transmembrane transport—SLC22A1—hematologic cancer	2.84e-05	0.00588	CbGpPWpGaD
Aminolevulinic acid—SLC15A2—Transmembrane transport of small molecules—S100A10—hematologic cancer	2.84e-05	0.00588	CbGpPWpGaD
Aminolevulinic acid—Vomiting—Prednisone—hematologic cancer	2.83e-05	0.000102	CcSEcCtD
Aminolevulinic acid—Rash—Prednisone—hematologic cancer	2.81e-05	0.000101	CcSEcCtD
Aminolevulinic acid—Dermatitis—Prednisone—hematologic cancer	2.81e-05	0.000101	CcSEcCtD
Aminolevulinic acid—Headache—Prednisone—hematologic cancer	2.79e-05	0.0001	CcSEcCtD
Aminolevulinic acid—SLC15A2—SLC-mediated transmembrane transport—NUP214—hematologic cancer	2.78e-05	0.00577	CbGpPWpGaD
Aminolevulinic acid—Gastrointestinal disorder—Doxorubicin—hematologic cancer	2.78e-05	9.98e-05	CcSEcCtD
Aminolevulinic acid—Urticaria—Epirubicin—hematologic cancer	2.77e-05	9.92e-05	CcSEcCtD
Aminolevulinic acid—Pain—Doxorubicin—hematologic cancer	2.76e-05	9.88e-05	CcSEcCtD
Aminolevulinic acid—Body temperature increased—Epirubicin—hematologic cancer	2.75e-05	9.87e-05	CcSEcCtD
Aminolevulinic acid—SLC15A1—SLC-mediated transmembrane transport—NUP98—hematologic cancer	2.68e-05	0.00555	CbGpPWpGaD
Aminolevulinic acid—Nausea—Prednisone—hematologic cancer	2.65e-05	9.49e-05	CcSEcCtD
Aminolevulinic acid—SLC15A2—Transmembrane transport of small molecules—SLC35B2—hematologic cancer	2.64e-05	0.00547	CbGpPWpGaD
Aminolevulinic acid—SLC15A1—Transmembrane transport of small molecules—S100A10—hematologic cancer	2.63e-05	0.00546	CbGpPWpGaD
Aminolevulinic acid—Pruritus—Methotrexate—hematologic cancer	2.63e-05	9.44e-05	CcSEcCtD
Aminolevulinic acid—SLC15A1—SLC-mediated transmembrane transport—NUP214—hematologic cancer	2.58e-05	0.00535	CbGpPWpGaD
Aminolevulinic acid—Urticaria—Doxorubicin—hematologic cancer	2.56e-05	9.18e-05	CcSEcCtD
Aminolevulinic acid—Body temperature increased—Doxorubicin—hematologic cancer	2.55e-05	9.14e-05	CcSEcCtD
Aminolevulinic acid—Diarrhoea—Methotrexate—hematologic cancer	2.55e-05	9.13e-05	CcSEcCtD
Aminolevulinic acid—SLC15A2—Transmembrane transport of small molecules—ATP1B1—hematologic cancer	2.48e-05	0.00514	CbGpPWpGaD
Aminolevulinic acid—Pruritus—Epirubicin—hematologic cancer	2.46e-05	8.84e-05	CcSEcCtD
Aminolevulinic acid—SLC15A1—Transmembrane transport of small molecules—SLC35B2—hematologic cancer	2.45e-05	0.00507	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—NQO1—hematologic cancer	2.43e-05	0.00503	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—CD44—hematologic cancer	2.43e-05	0.00503	CbGpPWpGaD
Aminolevulinic acid—Diarrhoea—Epirubicin—hematologic cancer	2.38e-05	8.55e-05	CcSEcCtD
Aminolevulinic acid—Vomiting—Methotrexate—hematologic cancer	2.37e-05	8.49e-05	CcSEcCtD
Aminolevulinic acid—SLC15A2—Transmembrane transport of small molecules—SLC26A4—hematologic cancer	2.35e-05	0.00487	CbGpPWpGaD
Aminolevulinic acid—Rash—Methotrexate—hematologic cancer	2.35e-05	8.41e-05	CcSEcCtD
Aminolevulinic acid—Dermatitis—Methotrexate—hematologic cancer	2.34e-05	8.41e-05	CcSEcCtD
Aminolevulinic acid—Headache—Methotrexate—hematologic cancer	2.33e-05	8.36e-05	CcSEcCtD
Aminolevulinic acid—SLC15A1—Transmembrane transport of small molecules—ATP1B1—hematologic cancer	2.3e-05	0.00477	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—CYCS—hematologic cancer	2.3e-05	0.00476	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—HSP90AA1—hematologic cancer	2.28e-05	0.00473	CbGpPWpGaD
Aminolevulinic acid—Pruritus—Doxorubicin—hematologic cancer	2.28e-05	8.18e-05	CcSEcCtD
Aminolevulinic acid—Vomiting—Epirubicin—hematologic cancer	2.21e-05	7.94e-05	CcSEcCtD
Aminolevulinic acid—Nausea—Methotrexate—hematologic cancer	2.21e-05	7.93e-05	CcSEcCtD
Aminolevulinic acid—Diarrhoea—Doxorubicin—hematologic cancer	2.2e-05	7.91e-05	CcSEcCtD
Aminolevulinic acid—Rash—Epirubicin—hematologic cancer	2.2e-05	7.87e-05	CcSEcCtD
Aminolevulinic acid—Dermatitis—Epirubicin—hematologic cancer	2.19e-05	7.87e-05	CcSEcCtD
Aminolevulinic acid—SLC15A1—Transmembrane transport of small molecules—SLC26A4—hematologic cancer	2.18e-05	0.00452	CbGpPWpGaD
Aminolevulinic acid—Headache—Epirubicin—hematologic cancer	2.18e-05	7.82e-05	CcSEcCtD
Aminolevulinic acid—SLC15A2—Transmembrane transport of small molecules—ANXA2—hematologic cancer	2.15e-05	0.00446	CbGpPWpGaD
Aminolevulinic acid—SLC15A2—Transmembrane transport of small molecules—ATP4A—hematologic cancer	2.15e-05	0.00446	CbGpPWpGaD
Aminolevulinic acid—SLC15A2—Transmembrane transport of small molecules—SGK1—hematologic cancer	2.15e-05	0.00446	CbGpPWpGaD
Aminolevulinic acid—Nausea—Epirubicin—hematologic cancer	2.07e-05	7.42e-05	CcSEcCtD
Aminolevulinic acid—Vomiting—Doxorubicin—hematologic cancer	2.05e-05	7.35e-05	CcSEcCtD
Aminolevulinic acid—Rash—Doxorubicin—hematologic cancer	2.03e-05	7.29e-05	CcSEcCtD
Aminolevulinic acid—Dermatitis—Doxorubicin—hematologic cancer	2.03e-05	7.28e-05	CcSEcCtD
Aminolevulinic acid—ALAD—Metabolism—GSTP1—hematologic cancer	2.03e-05	0.0042	CbGpPWpGaD
Aminolevulinic acid—Headache—Doxorubicin—hematologic cancer	2.02e-05	7.24e-05	CcSEcCtD
Aminolevulinic acid—SLC15A1—Transmembrane transport of small molecules—ATP4A—hematologic cancer	2e-05	0.00414	CbGpPWpGaD
Aminolevulinic acid—SLC15A1—Transmembrane transport of small molecules—SGK1—hematologic cancer	2e-05	0.00414	CbGpPWpGaD
Aminolevulinic acid—SLC15A1—Transmembrane transport of small molecules—ANXA2—hematologic cancer	2e-05	0.00414	CbGpPWpGaD
Aminolevulinic acid—SLC15A2—Transmembrane transport of small molecules—TUBB2A—hematologic cancer	1.94e-05	0.00401	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—ABCB1—hematologic cancer	1.92e-05	0.00397	CbGpPWpGaD
Aminolevulinic acid—Nausea—Doxorubicin—hematologic cancer	1.91e-05	6.86e-05	CcSEcCtD
Aminolevulinic acid—ALAD—Metabolism—GSTM1—hematologic cancer	1.86e-05	0.00386	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—NCOR1—hematologic cancer	1.86e-05	0.00386	CbGpPWpGaD
Aminolevulinic acid—SLC15A1—Transmembrane transport of small molecules—TUBB2A—hematologic cancer	1.8e-05	0.00372	CbGpPWpGaD
Aminolevulinic acid—SLC15A2—Transmembrane transport of small molecules—ABCC3—hematologic cancer	1.7e-05	0.00352	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—MTHFR—hematologic cancer	1.65e-05	0.00341	CbGpPWpGaD
Aminolevulinic acid—SLC15A1—Transmembrane transport of small molecules—ABCC3—hematologic cancer	1.58e-05	0.00327	CbGpPWpGaD
Aminolevulinic acid—SLC15A2—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	1.55e-05	0.00322	CbGpPWpGaD
Aminolevulinic acid—SLC15A2—Transmembrane transport of small molecules—NUP98—hematologic cancer	1.47e-05	0.00304	CbGpPWpGaD
Aminolevulinic acid—SLC15A1—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	1.44e-05	0.00299	CbGpPWpGaD
Aminolevulinic acid—SLC15A2—Transmembrane transport of small molecules—ADCY7—hematologic cancer	1.42e-05	0.00295	CbGpPWpGaD
Aminolevulinic acid—SLC15A2—Transmembrane transport of small molecules—NUP214—hematologic cancer	1.41e-05	0.00293	CbGpPWpGaD
Aminolevulinic acid—SLC15A2—Transmembrane transport of small molecules—ABCG2—hematologic cancer	1.39e-05	0.00287	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—PIK3CG—hematologic cancer	1.38e-05	0.00286	CbGpPWpGaD
Aminolevulinic acid—SLC15A1—Transmembrane transport of small molecules—NUP98—hematologic cancer	1.36e-05	0.00282	CbGpPWpGaD
Aminolevulinic acid—SLC15A1—Transmembrane transport of small molecules—ADCY7—hematologic cancer	1.32e-05	0.00274	CbGpPWpGaD
Aminolevulinic acid—SLC15A1—Transmembrane transport of small molecules—NUP214—hematologic cancer	1.31e-05	0.00272	CbGpPWpGaD
Aminolevulinic acid—SLC15A1—Transmembrane transport of small molecules—ABCG2—hematologic cancer	1.29e-05	0.00267	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—CREBBP—hematologic cancer	1.28e-05	0.00266	CbGpPWpGaD
Aminolevulinic acid—SLC15A2—Transmembrane transport of small molecules—TFRC—hematologic cancer	1.24e-05	0.00256	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—PIK3CD—hematologic cancer	1.22e-05	0.00252	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—ALB—hematologic cancer	1.2e-05	0.00249	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—PIK3R1—hematologic cancer	1.15e-05	0.00238	CbGpPWpGaD
Aminolevulinic acid—SLC15A1—Transmembrane transport of small molecules—TFRC—hematologic cancer	1.15e-05	0.00238	CbGpPWpGaD
Aminolevulinic acid—SLC15A2—SLC-mediated transmembrane transport—ALB—hematologic cancer	1.06e-05	0.00221	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—PIK3CB—hematologic cancer	1.06e-05	0.00219	CbGpPWpGaD
Aminolevulinic acid—SLC15A2—Transmembrane transport of small molecules—CYCS—hematologic cancer	1.04e-05	0.00215	CbGpPWpGaD
Aminolevulinic acid—SLC15A1—SLC-mediated transmembrane transport—ALB—hematologic cancer	9.88e-06	0.00205	CbGpPWpGaD
Aminolevulinic acid—SLC15A1—Transmembrane transport of small molecules—CYCS—hematologic cancer	9.62e-06	0.00199	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—PTEN—hematologic cancer	9.15e-06	0.0019	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—EP300—hematologic cancer	8.73e-06	0.00181	CbGpPWpGaD
Aminolevulinic acid—SLC15A2—Transmembrane transport of small molecules—ABCB1—hematologic cancer	8.65e-06	0.00179	CbGpPWpGaD
Aminolevulinic acid—SLC15A1—Transmembrane transport of small molecules—ABCB1—hematologic cancer	8.03e-06	0.00166	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—PIK3CA—hematologic cancer	6.46e-06	0.00134	CbGpPWpGaD
Aminolevulinic acid—SLC15A2—Transmembrane transport of small molecules—CREBBP—hematologic cancer	5.78e-06	0.0012	CbGpPWpGaD
Aminolevulinic acid—SLC15A2—Transmembrane transport of small molecules—ALB—hematologic cancer	5.41e-06	0.00112	CbGpPWpGaD
Aminolevulinic acid—SLC15A1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	5.37e-06	0.00111	CbGpPWpGaD
Aminolevulinic acid—ALAD—Metabolism—AKT1—hematologic cancer	5.27e-06	0.00109	CbGpPWpGaD
Aminolevulinic acid—SLC15A1—Transmembrane transport of small molecules—ALB—hematologic cancer	5.02e-06	0.00104	CbGpPWpGaD
